Lili Ding

Dr. Lili Ding

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2011 in BMC Genomics
Verified
Journal Article
Open access
PDF file
LDLili Ding
Lili Ding
HWHoward Wiener
Howard Wiener
TATilahun Abebe
Tilahun Abebe
MAMekbib Altaye
Mekbib Altaye
RGRodney Cp Go
Rodney Cp Go
Tesfaye MershaTesfaye Mersha
Tesfaye Mersha
Background: Admixture mapping is a powerful gene mapping approach for an admixed population formed from ancestral populations with different allele frequencies. The power of this method relies on the ability of ancestry informative markers (AIMs) to infer ancestry along the chromosomes of admixed individuals. In this study, more than one million SNPs from HapMap databases and simulated data have been interrogated in admixed populations using various measures of ancestry informativeness: Fisher Information Content (FIC), Shannon Information Content (SIC), F statistics (FST), Informativeness for Assignment Measure (In), and the Absolute Allele Frequency Differences (delta, δ). The objectives are to compare these measures of informativeness to select SNP markers for ancestry inference, and to determine the accuracy of AIM panels selected by each measure in estimating the contributions of the ancestors to the admixed population. Results: FST and In had the highest Spearman correlation and the best agreement as measured by Kappa statistics based on deciles. Although the different measures of marker informativeness performed comparably well, analyses based on the top 1 to 10% ranked informative markers of simulated data showed that In was better in estimating ancestry for an admixed population. Conclusions: Although millions of SNPs have been identified, only a small subset needs to be genotyped in order to accurately predict ancestry with a minimal error rate in a cost-effective manner. In this article, we compared various methods for selecting ancestry informative SNPs using simulations as well as SNP genotype data from samples of admixed populations and showed that the In measure estimates ancestry proportion (in an admixed population) with lower bias and mean square error.

5 July 2013 in Human Genomics
Verified
Journal Article
Open access
PDF file
LDLili Ding
Lili Ding
TATilahun Abebe
Tilahun Abebe
JBJoseph Beyene
Joseph Beyene
RWRussell A Wilke
Russell A Wilke
AGArnon Goldberg
Arnon Goldberg
Tesfaye MershaTesfaye Mersha
Tesfaye Mersha
Background: The standard approach to determine unique or shared genetic factors across populations is to identify risk alleles in one population and investigate replication in others. However, since populations differ in DNA sequence information, allele frequencies, effect sizes, and linkage disequilibrium patterns, SNP association using a uniform stringent threshold on p values may not be reproducible across populations. Here, we developed rank-based methods to investigate shared or population-specific loci and pathways for childhood asthma across individuals of diverse ancestry. We performed genome-wide association studies on 859,790 SNPs genotyped in 527 affected offspring trios of European, African, and Hispanic ancestry using publically available asthma database in the Genotypes and Phenotypes database. Results: Rank-based analyses showed that there are shared genetic factors for asthma across populations, more at the gene and pathway levels than at the SNP level. Although the top 1,000 SNPs were not shared, 11 genes (RYR2, PDE4D, CSMD1, CDH13, ROBO2, RBFOX1, PTPRD, NPAS3, PDE1C, SEMA5A, and CTNNA2) mapped by these SNPs were shared across populations. Ryanodine receptor 2 (RYR2, a statin response-related gene) showed the strongest association in European (p value = 2.55 × 10−7) and was replicated in African (2.57 × 10−4) and Hispanic (1.18 × 10−3) Americans. Imputation analyses based on the 1000 Genomes Project uncovered additional RYR2 variants associated with asthma. Network and functional ontology analyses revealed that RYR2 is an integral part of dermatological or allergic disorder biological networks, specifically in the functional classes involving inflammatory, eosinophilic, and respiratory diseases. Conclusion: Our rank-based genome-wide analysis revealed for the first time an association of RYR2 variants with asthma and replicated previously discovered PDE4D asthma gene across human populations. The replication of top-ranked asthma genes across populations suggests that such loci are less likely to be false positives and could indicate true associations. Variants that are associated with asthma across populations could be used to identify individuals who are at high risk for asthma regardless of genetic ancestry.

29 November 2011 in BMC Proceedings
Verified
Journal Article
Open access
PDF file
Tesfaye MershaTesfaye Mersha
Tesfaye Mersha
HHHua He
Hua He
LDLili Ding
Lili Ding
BKBrad G Kurowski
Brad G Kurowski
XZXue Zhang
Xue Zhang
LMLisa Martin
Lisa Martin
Next-generation sequencing technologies now make it possible to genotype and measure hundreds of thousands of rare genetic variations in individuals across the genome. Characterization of high-density genetic variation facilitates control of population genetic structure on a finer scale before large-scale genotyping in disease genetics studies. Population structure is a well-known, prevalent, and important factor in common variant genetic studies, but its relevance in rare variants is unclear. We perform an extensive population structure analysis using common and rare functional variants from the Genetic Analysis Workshop 17 mini-exome sequence. The analysis based on common functional variants required 388 principal components to account for 90% of the variation in population structure. However, an analysis based on rare variants required 532 significant principal components to account for similar levels of variation. Using rare variants, we detected fine-scale substructure beyond the population structure identified using common functional variants. Our results show that the level of population structure embedded in rare variant data is different from the level embedded in common variant data and that correcting for population structure is only as good as the level one wishes to correct.

12 July 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
VOVanessa A Olbrecht
Vanessa A Olbrecht
KOKeith T O'Conor
Keith T O'Conor
SWSara Williams
Sara Williams
CBChloe O Boehmer
Chloe O Boehmer
GMGilbert W Marchant
Gilbert W Marchant
CKChristopher D King
Christopher D King
Background: Distraction-based therapies, such as virtual reality (VR), have been used to reduce pain during acutely painful procedures. However, distraction alone cannot produce prolonged pain reduction to manage sustained postoperative pain. Therefore, the integration of VR with other pain-reducing therapies, like guided relaxation, may enhance its clinical impact. Objective: The goal of this pilot study was to assess the impact of a single guided relaxation–based VR (VR-GR) session on postoperative pain and anxiety reduction in children. We also explored the influence of pain catastrophizing and anxiety sensitivity on this association. Methods: A total of 51 children and adolescents (7-21 years) with postoperative pain and followed by the Acute Pain Service at Cincinnati Children’s Hospital were recruited over an 8-month period to undergo a single VR-GR session. Prior to VR, the patients completed 2 questionnaires: Pain Catastrophizing Scale for Children (PCS-C) and the Child Anxiety Sensitivity Index (CASI). The primary outcome was a change in pain intensity following the VR-GR session (immediately, 15 minutes, and 30 minutes). The secondary outcomes included changes in pain unpleasantness and anxiety. Results: The VR-GR decreased pain intensity immediately (P<.001) and at 30 minutes (P=.04) after the VR session, but not at 15 minutes (P=.16) postsession. Reductions in pain unpleasantness were observed at all time intervals (P<.001 at all intervals). Anxiety was reduced immediately (P=.02) but not at 15 minutes (P=.08) or 30 minutes (P=.30) following VR-GR. Patients with higher CASI scores reported greater reductions in pain intensity (P=.04) and unpleasantness (P=.01) following VR-GR. Pain catastrophizing was not associated with changes in pain and anxiety. Conclusions: A single, short VR-GR session showed transient reductions in pain intensity, pain unpleasantness, and anxiety in children and adolescents with acute postoperative pain. The results call for a future randomized controlled trial to assess the efficacy of VR-GR. Trial Registration: ClinicalTrials.gov NCT04556747; https://clinicaltrials.gov/ct2/show/NCT04556747

1 February 2026 in Stroke
Verified
Journal Article
Closed access
DRDavid Robinson
David Robinson
LDLili Ding
Lili Ding
RSRobert J. Stanton
Robert J. Stanton
EMEva Mistry
Eva Mistry
DKDawn Kleindorfer
Dawn Kleindorfer
BKBrett Kissela
Brett Kissela
BACKGROUND: Despite a rising public health burden, there have been few population-based studies of chronic subdural hematomas (cSDH) in the United States. We provide the first estimates of cSDH incidence and mortality in a large, representative U.S. population. METHODS: In a representative 5-county region of Southern Ohio and Northern Kentucky, all adults with cSDH in 2019 and 2020 were identified and adjudicated by study physicians. Incidence rates were estimated and standardized to the US population based on age, sex, and race; 30-day and 1-year mortality rates were also estimated. The cause of death was determined using the National Death Index. RESULTS: A total of 353 patients with cSDH were identified. The median age was 76 (IQR, 65–85), 231 were men (65.4%), and 78 were Black (22.1%). Clinical frailty was prevalent among patients (the median retrospective score on the clinical frailty scale was 4), and only 128 (36.3%) were functionally unimpaired at baseline. The regional incidence rate was 16.3 cases/100 000 persons/y (95% CI, 13.9–19.0). Incidence was age- and sex-dependent, with men 85 and older having an incidence rate of 354.8 cases/100 000 persons/y (95% CI, 242.7–500.9). When adjusted to national demographics, the estimated overall US incidence rate was 17.3 cases/100 000 persons/y (95% CI, 14.7–19.9). The 30-day mortality rate after cSDH was 9.4% (95% CI, 6.5–12.9), and the 1-year mortality rate was 32.9% (28.0–38.0). Early mortality (≤30 days) was often partly or fully attributed to the cSDH (48.4% versus 16.1%; P =0.0004), whereas the most common causes of later mortality were neurodegenerative and cardiovascular diseases (27.2% and 28.4%, respectively). CONCLUSIONS: Our contemporary population-level data show that cSDH is common in the US and primarily afflicts patients with a high degree of functional impairment and frailty. While short-term mortality is low, longer-term mortality is high and often related to comorbid illnesses.

Melinda Mahabee-GittensMelinda Mahabee-Gittens
Melinda Mahabee-Gittens
RARobert T. Ammerman
Robert T. Ammerman
JKJane C. Khoury
Jane C. Khoury
MTMeredith E. Tabangin
Meredith E. Tabangin
LDLili Ding
Lili Ding
JGJudith S. Gordon
Judith S. Gordon
We examined the efficacy of a pediatric emergency visit-based screening, brief intervention, and referral to treatment (SBIRT) condition compared to a control condition (Healthy Habits Control, HHC) to help parental smokers quit smoking. We enrolled 750 parental smokers who presented to the pediatric emergency setting with their child into a two-group randomized controlled clinical trial. SBIRT participants received brief cessation coaching, quitting resources, and up to 12-weeks of nicotine replacement therapy (NRT). HHC participants received healthy lifestyle coaching and resources. The primary outcome was point-prevalence tobacco abstinence at six weeks (T1) and six months (T2). The mean (SD) age of parents was 31.8 (7.7) years, and 86.8% were female, 52.7% were Black, and 64.6% had an income of ≤$15,000. Overall abstinence rates were not statistically significant with 4.2% in both groups at T1 and 12.9% and 8.3% in the SBIRT and HHC groups, respectively, at T2. There were statistically significant differences in SBIRT versus HHC participants on the median (IQR) reduction of daily cigarettes smoked at T1 from baseline (−2 [−5, 0] versus 0 [−4, 0], p = 0.0008),at T2 from baseline (−4 [−9, −1] vs. −2 [−5, 0], p = 0.0006), and on the mean (SD) number of quit attempts at T2 from baseline (1.25 (6.5) vs. 0.02 (4.71), p = 0.02). Self-reported quitting rates were higher in SBIRT parents who received NRT (83.3% vs. 50.9%, p = 0.04). The novel use of the pediatric emergency visit to conduct cessation interventions helped parents quit smoking. The near equivalent abstinence rates in both the SBIRT and HHC groups may be due to underlying parental concern about their child’s health. Cessation interventions in this setting may result in adult and pediatric public health benefits.